Skip to content
OpenCapital
Get started

iBio IBIO Q4 2024 earnings

Reported February 10, 2025 · Before market open

Revenue$200.0K
EPS-$0.48Miss by $0.03
EPS estimate-$0.45

Next report

Sep 4, 2026 (in a month)
Revenue estimate$33.3K
EPS estimate-$0.07

Versus estimates

Revenue

Q3 2025$100.0KBeat by $66.7KQ2 2025$200.0KBeat by $100.0K
Q4 2024$200.0K

Diluted EPS

Q1 2026-$0.07Miss by $0.01Q4 2025-$0.09Miss by $0.01Q3 2025-$0.11Miss by $0.04Q2 2025-$0.31Beat by $0.08Q1 2025-$0.49Miss by $0.10
Q4 2024-$0.48Miss by $0.03

Ask the moment iBio reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did iBio report Q4 2024 earnings?
iBio (IBIO) reported Q4 2024 earnings on February 10, 2025 before market open.
What were iBio's Q4 2024 revenue and EPS?
iBio reported revenue of $200.0K and eps of $-0.48 for Q4 2024.
Did iBio beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.45 by $0.03.
Where can I find iBio's Q4 2024 SEC filings?
You can read the 10-Q periodic report (0001420720-25-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.